Daniel K. Burns

5.8k total citations
80 papers, 4.0k citations indexed

About

Daniel K. Burns is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Daniel K. Burns has authored 80 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 20 papers in Physiology and 15 papers in Immunology. Recurrent topics in Daniel K. Burns's work include Alzheimer's disease research and treatments (12 papers), Dementia and Cognitive Impairment Research (12 papers) and Genetic Associations and Epidemiology (9 papers). Daniel K. Burns is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Dementia and Cognitive Impairment Research (12 papers) and Genetic Associations and Epidemiology (9 papers). Daniel K. Burns collaborates with scholars based in United States, United Kingdom and Switzerland. Daniel K. Burns's co-authors include Alan R. Shuldiner, John M. Rumberger, David P. Yarnall, Allen D. Roses, Ann M. Saunders, Margaret G. Ehm, David H. Presky, Michael W. Lutz, Barry A. Wolitzky and Chung‐Jen Yen and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Daniel K. Burns

79 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel K. Burns United States 31 2.1k 1.0k 914 521 498 80 4.0k
L. Vicentini Italy 41 2.6k 1.3× 855 0.8× 250 0.3× 301 0.6× 684 1.4× 106 5.0k
James D. Clark United States 34 3.2k 1.5× 979 1.0× 579 0.6× 185 0.4× 1.3k 2.5× 77 6.3k
Takanobu Taniguchi Japan 33 1.5k 0.7× 473 0.5× 436 0.5× 195 0.4× 302 0.6× 105 3.1k
Hisakazu Ogita Japan 38 2.4k 1.1× 474 0.5× 257 0.3× 334 0.6× 690 1.4× 100 4.9k
Michael A. Crackower United States 28 2.9k 1.4× 487 0.5× 588 0.6× 123 0.2× 416 0.8× 42 6.9k
Kazuhiro Oka United States 34 1.9k 0.9× 391 0.4× 770 0.8× 121 0.2× 449 0.9× 74 3.8k
Randal A. Skidgel United States 48 2.7k 1.3× 895 0.9× 274 0.3× 161 0.3× 723 1.5× 120 6.5k
Uwe Lendeckel Germany 46 2.1k 1.0× 410 0.4× 268 0.3× 240 0.5× 473 0.9× 186 6.4k
Kirk U. Knowlton United States 39 3.4k 1.6× 652 0.6× 485 0.5× 96 0.2× 684 1.4× 157 6.8k
Yoshihiro Kita Japan 34 1.5k 0.7× 633 0.6× 161 0.2× 327 0.6× 763 1.5× 118 4.1k

Countries citing papers authored by Daniel K. Burns

Since Specialization
Citations

This map shows the geographic impact of Daniel K. Burns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel K. Burns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel K. Burns more than expected).

Fields of papers citing papers by Daniel K. Burns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel K. Burns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel K. Burns. The network helps show where Daniel K. Burns may publish in the future.

Co-authorship network of co-authors of Daniel K. Burns

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel K. Burns. A scholar is included among the top collaborators of Daniel K. Burns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel K. Burns. Daniel K. Burns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watts, Amber, Stephen Haneline, Kathleen A. Welsh‐Bohmer, et al.. (2023). TOMM40 ‘523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOE ɛ3 Homozygotes. Journal of Alzheimer s Disease. 95(4). 1697–1707. 1 indexed citations
2.
Flynn, Loren L., Ryan S. Anderton, Frank Mastaglia, et al.. (2020). Disease-modifying effects of an SCAF4 structural variant in a predominantly SOD1 ALS cohort. Neurology Genetics. 6(4). 8 indexed citations
3.
Yu, Lei, Michael W. Lutz, Robert S. Wilson, et al.. (2017). APOE ε4-TOMM40 ‘523 haplotypes and the risk of Alzheimer’s disease in older Caucasian and African Americans. PLoS ONE. 12(7). e0180356–e0180356. 48 indexed citations
4.
Lutz, Michael W., Donna G. Crenshaw, Kathleen A. Welsh‐Bohmer, Daniel K. Burns, & Allen D. Roses. (2016). New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics. Current Neurology and Neuroscience Reports. 16(5). 48–48. 27 indexed citations
5.
Gottschalk, William, Michael W. Lutz, Yu He, et al.. (2014). Journal of Parkinson’s disease & Alzheimer’s disease. PubMed. 1(1). 67 indexed citations
6.
Linnertz, Colton L., Ann M. Saunders, Michael W. Lutz, et al.. (2012). Characterization of the Poly-T Variant in the TOMM40 Gene in Diverse Populations. PLoS ONE. 7(2). e30994–e30994. 46 indexed citations
7.
Crenshaw, Donna G., William Gottschalk, Michael W. Lutz, et al.. (2012). Using Genetics to Enable Studies on the Prevention of Alzheimer’s Disease. Clinical Pharmacology & Therapeutics. 93(2). 177–185. 59 indexed citations
8.
Burns, Daniel K.. (2010). Developing Pharmacogenetic Evidence Throughout Clinical Development. Clinical Pharmacology & Therapeutics. 88(6). 867–870. 8 indexed citations
9.
Akkari, P. Anthony, Donna G. Crenshaw, Iris Grossman, et al.. (2009). Pipeline Pharmacogenetics: A Novel Approach to Integrating Pharmacogenetics into Drug Development. Current Pharmaceutical Design. 15(32). 3754–3763. 6 indexed citations
10.
Hughes, Arlene R., William Spreen, Michael Mosteller, et al.. (2008). Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility. The Pharmacogenomics Journal. 8(6). 365–374. 61 indexed citations
11.
Richardson, James A. & Daniel K. Burns. (2002). Mouse Models of Alzheimer's Disease: A Quest for Plaques. ILAR Journal. 43(2). 89–99. 40 indexed citations
12.
Hanson, Robert L., Margaret G. Ehm, David J. Pettitt, et al.. (1998). An Autosomal Genomic Scan for Loci Linked to Type II Diabetes Mellitus and Body-Mass Index in Pima Indians. The American Journal of Human Genetics. 63(4). 1130–1138. 382 indexed citations
13.
Esser, Victoria, Daniel W. Foster, Daniel K. Burns, et al.. (1997). Fine Chromosome Mapping of the Genes for Human Liver and Muscle Carnitine Palmitoyltransferase I (CPT1A and CPT1B). Genomics. 40(1). 209–211. 72 indexed citations
14.
Burns, Daniel K., et al.. (1995). Identification and Characterization of a Novel Cytokine-inducible Nuclear Protein from Human Endothelial Cells. Journal of Biological Chemistry. 270(17). 10236–10245. 100 indexed citations
15.
Best, Jennifer L., David H. Presky, Robert A. Swerlick, Daniel K. Burns, & Wuying Chu. (1995). Cloning of a Full-Length cDNA Sequence Encoding a cdc2-Related Protein Kinase from Human Endothelial Cells. Biochemical and Biophysical Research Communications. 208(2). 562–568. 1 indexed citations
16.
Presky, David H., et al.. (1994). Identification and characterization of DBK, a novel putative serine/threonine protein kinase from human endothelial cells. European Journal of Biochemistry. 225(2). 695–702. 2 indexed citations
17.
Labow, Mark, Christine R. Norton, John M. Rumberger, et al.. (1994). Characterization of E-selectin-deficient mice: Demonstration of overlapping function of the endothelial selectins. Immunity. 1(8). 709–720. 318 indexed citations
18.
Graves, Bradford, R. Crowther, John M. Rumberger, et al.. (1994). Insight into E-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/EGF domains. Nature. 367(6463). 532–538. 333 indexed citations
19.
Presky, David H., et al.. (1993). Human ribosomal protein S20 cDNA sequence. Nucleic Acids Research. 21(7). 1672–1672. 9 indexed citations
20.
Norton, Christine R., John M. Rumberger, Daniel K. Burns, & B A Wolitzky. (1993). Characterization of Murine E-Selectin Expression in Vitro Using Novel Anti-mouse E-Selectin Monoclonal Antibodies. Biochemical and Biophysical Research Communications. 195(1). 250–258. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Vicentini Breakdown of academic impact, for papers by James D. Clark Breakdown of academic impact, for papers by Takanobu Taniguchi Breakdown of academic impact, for papers by Hisakazu Ogita Breakdown of academic impact, for papers by Michael A. Crackower Breakdown of academic impact, for papers by Kazuhiro Oka Breakdown of academic impact, for papers by Randal A. Skidgel Breakdown of academic impact, for papers by Uwe Lendeckel Breakdown of academic impact, for papers by Kirk U. Knowlton Breakdown of academic impact, for papers by Yoshihiro Kita
Rankless by CCL
2026